Skip to main content

Guideline-Concordance With Durvalumab in Stage 3 Non-Small Cell Lung Cancer: A Single Institution Experience

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Guideline-Concordance With Durvalumab in Stage 3 Non-Small Cell Lung Cancer: A Single Institution Experience

User login

Username

Password

Reset your password

Type	Lead	score